Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster dose of inactivated Vero-cell Japanese encephalitis vaccine (JEVAC) in children primed with live attenuated JE vaccine
TCTR20220412006Phase 4Not yet recruiting
- Sponsor
- Biovalys
- Start
- Apr 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of japanese encephalitis vaccine (vero cell), inactivated in Japanese encephalitis (JE), sponsored by Biovalys. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
japanese encephalitis vaccine (vero cell), inactivated
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on TCTR20220412006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220412006.